MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Association between dysphagia and body mass index and his impact on the severity of anxiety in patients with Parkinson Disease

EC. Santiago, AJ. Hernández Medrano, MA. Ruiz Mafud, AA. Herrera Ruiz, DR. Aguilar Godinez, LG. Lira Juárez, MA. Medrano Delgado, AM. Regalado Mustafá, A. Domínguez García, G. Hernandez Armesto, DP. Romero Terán, K. Talavera Lagunas, MF. Medina-Pérez, JF. García Hernández, A. Abundes-Corona, GI. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga (MÉXICO, Mexico)

Meeting: 2023 International Congress

Abstract Number: 511

Keywords: Parkinson’s

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: To describe the relation between dysphagia and body mass index and the increase in anxiety and depression in patients with parkinson’s disease.

Background: Parkinson’s is a neurodegenerative disease that appears classically with motor symptoms such as bradykinesia, rigidity, tremor, and posture instability. Almost 24% of patients with PD have denutrition associated with increased energetic expenditure and dysphagia. More than 80 % of patients with Parkinson’s disease (PD) develop dysphagia during the course of their disease. People living with Parkinson’s have 52-65% dyskinesia and rapid progression tends to be more in women.

Method: A longitudinal retrospective study was performed. A demographic and epidemiologic questionary where applied which determines gender, age, weight, size, and body mass index,  for the descriptive statistics. MDS UPDRS 2.3 was used to evaluate chewing and deglutition, Hamilton Depression Rating Scale (HRSD), and Hamilton Anxiety Rating Scale (HRSA). Group 1 patients with symptoms and group 2 without symptoms.

Results: 36 patients were included which 78 were men and 58 were women. The average age was 62 ±12.5 years old. Anova Test was used with a mean of 2.8 in the severe stage of the UPDR 2.3. A statistical cross table was used to compare both groups having (p=0.883). An additional Hamilton test was performed with a mean of 11.92.

Conclusion: The comparison between both groups didn’t show a significant difference between dysphagia and the body mass index nor depression or anxiety. The UPDRS 2.3 chewing and deglutition domain is not a specific tool to measure the impact of dysphagia.

To cite this abstract in AMA style:

EC. Santiago, AJ. Hernández Medrano, MA. Ruiz Mafud, AA. Herrera Ruiz, DR. Aguilar Godinez, LG. Lira Juárez, MA. Medrano Delgado, AM. Regalado Mustafá, A. Domínguez García, G. Hernandez Armesto, DP. Romero Terán, K. Talavera Lagunas, MF. Medina-Pérez, JF. García Hernández, A. Abundes-Corona, GI. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga. Association between dysphagia and body mass index and his impact on the severity of anxiety in patients with Parkinson Disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/association-between-dysphagia-and-body-mass-index-and-his-impact-on-the-severity-of-anxiety-in-patients-with-parkinson-disease/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/association-between-dysphagia-and-body-mass-index-and-his-impact-on-the-severity-of-anxiety-in-patients-with-parkinson-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley